Insights into Chemoresistance of Prostate Cancer

International Journal of Biological Sciences
Wei ZhangTao Yang

Abstract

Prostate cancer (PCa) remains the most prevalent malignancy among males in the western world. Though hormonal therapies through chemical or surgical castration have been proposed many years ago, heretofore, such mainstay for the treatment on advanced PCa has not fundamentally changed. These therapeutic responses are temporary and most cases will eventually undergo PCa recurrence and metastasis, or even progress to castration-resistant prostate cancer (CRPC) due to persistent development of drug resistance. Prostate cancer stem cells (PCSCs) are a small population of cells, which possess unlimited self-renewal capacities, and can regenerate tumorigenic progenies, and play an essential role in PCa therapy resistance, metastasis and recurrence. Nowadays advanced progresses have been made in understanding of PCSC properties, roles of androgen receptor signaling and ATP-binding cassette sub-family G member 2 (ABCG2), as well as roles of genomic non-coding microRNAs and key signaling pathways, which have led to the development of novel therapies which are active against chemoresistant PCa and CRPC. Based on these progresses, this review is dedicated to address mechanisms underlying PCa chemoresistance, unveil crosstalks among pivotal...Continue Reading

Citations

Feb 24, 2016·Current Opinion in Biotechnology·Emma E van der ToomKenneth J Pienta
May 18, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia NovíoMaría Jesús Núñez-Iglesias
Jun 9, 2016·PloS One·Aigul ZhunussovaZulfiya Orynbayeva
Jan 19, 2017·International Journal of Molecular Sciences·Massimiliano CadamuroLuca Fabris
May 5, 2017·Anti-cancer Drugs·Marilina García-ArandaMaximino Redondo
Dec 12, 2017·Journal of Nutritional Science and Vitaminology·Chiaki SatoTomohiro Yano
Apr 7, 2020·Current Pharmaceutical Design·Qiang LiuZhi-Xiang Yuan
Jul 2, 2019·Journal of Nutritional Science and Vitaminology·Saki KanekoTomohiro Yano
Jan 29, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J ValeroV Millan
Aug 31, 2017·Molecular Cancer·Fengming YangHua Shen
Sep 1, 2018·Cell Death & Disease·Riccardo CristofaniRoberta Manuela Moretti
Oct 9, 2020·Biomaterials Science·Xiaowei WangYuan Huang
Oct 17, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marine F GarridoAnne Chauchereau
Jan 15, 2017·Molecular Cancer Research : MCR·Mi ZhangEvan T Keller
Feb 24, 2020·Experimental and Molecular Pathology·Haoyue LiYanhua Xuan
Aug 29, 2020·The International Journal of Biochemistry & Cell Biology·Sara Teixeira Soares MotaThaise Gonçalves Araújo
May 23, 2021·Andrologia·Yun PengHaitao Wang
Jul 25, 2021·Photodiagnosis and Photodynamic Therapy·Shinkuro YamamotoKeiji Inoue

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
xenograft
chemical castration
xenografts

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.